I Like SpaceX, But I'm Not Buying the Stock for One Simple Reason

SpaceX reported approximately $7.8 billion in Q2 2026 revenue, up 92% year over year, including $4.3 billion from Starlink and $2.6 billion of AI-related revenue, which rose 247%. Despite strong operating momentum, the article argues that the $153 share price and roughly $2 trillion valuation already discount substantial future success against annualized revenue of $31.2 billion while the company remains unprofitable. Quarterly capital spending of $18.4 billion and potential Starship or Starlink execution setbacks could create a more attractive entry point.

Analysis

The investable signal is not a valuation call on SPCX; it is an information-quality and private-market-liquidity issue. SpaceX is not a Nasdaq-listed security, so the quoted public-market price, ticker, and segment disclosures should not be treated as independently actionable. Any secondary-market indication of a $2T valuation would imply an extreme revenue multiple and makes the equity unusually sensitive to a funding-round reset, employee-tender supply, or evidence that capital intensity remains permanently ahead of cash generation.

For listed equities, the more relevant transmission is competitive. If Starship materially reduces launch cost over the next 12-24 months, it pressures launch economics for RKLB and lowers constellation deployment costs for satellite operators; the latter is beneficial only if cheaper capacity does not trigger a Starlink-led pricing response. IRDM and ASTS face the more immediate strategic risk from satellite-to-device and broadband substitution, while NVDA should not be read through from unverified claims of SpaceX AI revenue: there is no disclosed basis to model a material incremental GPU demand impulse.

Consensus tends to frame SpaceX as a singular winner, missing that lower launch costs can commoditize the orbital infrastructure layer before they create durable end-market profits. The key 1-3 month catalyst is a credible private tender or financing with verified valuation, capex, and cash-flow terms; over 6-18 months, commercial Starship cadence and Starlink ARPU/churn—not subscriber growth alone—determine whether the business earns returns above its capital cost. A verified increase in satellite-service pricing, accelerating operator churn, or a sustained step-down in launch cost would falsify the cautious competitive view.

Key Decisions for Investors

• No direct SPCX position: treat the article’s security identifier and financial figures as unverified until confirmed by a credible private tender, company filing, or institutional secondary-market documentation.
• Maintain RKLB as a 6-18 month relative-value short/watch candidate versus XAR only after a verified Starship commercial-cadence milestone; lower launch pricing would compress RKLB’s addressable launch-margin assumptions. Stop the thesis if RKLB secures multi-year contracted backlog at pricing that preserves gross-margin guidance.
• Monitor a long IRDM / short ASTS pair over the next 3-6 months rather than making a directional SpaceX bet. IRDM has an established cash-generating network, while ASTS is more exposed to execution, financing, and competitive-capacity assumptions; exit if ASTS demonstrates funded, on-schedule deployment with contracted carrier economics that validate its ARPU model.
• Do not add NVDA exposure on this item. Reassess only if SpaceX-related compute procurement is corroborated in supplier commentary or NVDA data-center guidance; absent that evidence, the claimed AI linkage is narrative rather than an earnings catalyst.